Skip to main content
Premium Trial:

Request an Annual Quote

Mega Fight for Metadata Market

Premium

Could InforMax’s recent alliance with Biomax Informatics be the missing piece it has needed to go head-to-head with its primary competitor, Lion Bioscience? The deal gives InforMax distribution and co-marketing rights to the BioRS Integration and Retrieval System.

Steve Lincoln, senior vice president of life science informatics at InforMax, says that Martins- reid, Germany-based Biomax has positioned the BioRS technology to compete with Lion’s SRS platform. But Christian Marcazzo, Lion’s director of product marketing, isn’t worried. “I’m looking forward to the competition,” Marcazzo says. “It’s going to be fun.”

BioRS integrates heterogeneous public and proprietary databases. The new capability will support a “holistic system” that Lincoln says will set InforMax apart from competitors.

Marcazzo sees the adoption of BioRS as “validation of Lion’s metadata approach to data integration,” and claims that Lion is still one step ahead. “While Biomax and InforMax work together to try and catch up with us,” he says, “we’re actively working to start expanding the applicability of SRS into other domains.”

Through hitching its wagon to Informax, Biomax can gain access to Informax’s customer base of over 500 organizations throughout Europe, 150 of which are in Germany.

Lincoln acknowledges that the InforMax/Biomax partnership looks like an aggressive push onto Lion’s home turf, but says, “I don’t think this particular deal makes [the competition with Lion] any better or worse. This deal for us is part of our strategy of diversifying our product line.”

—Bernadette Toner

 

The Scan

Genetic Risk Factors for Hypertension Can Help Identify Those at Risk for Cardiovascular Disease

Genetically predicted high blood pressure risk is also associated with increased cardiovascular disease risk, a new JAMA Cardiology study says.

Circulating Tumor DNA Linked to Post-Treatment Relapse in Breast Cancer

Post-treatment detection of circulating tumor DNA may identify breast cancer patients who are more likely to relapse, a new JCO Precision Oncology study finds.

Genetics Influence Level of Depression Tied to Trauma Exposure, Study Finds

Researchers examine the interplay of trauma, genetics, and major depressive disorder in JAMA Psychiatry.

UCLA Team Reports Cost-Effective Liquid Biopsy Approach for Cancer Detection

The researchers report in Nature Communications that their liquid biopsy approach has high specificity in detecting all- and early-stage cancers.